Search Results 1051-1060 of 15706 for Break STD Taboo

  1. A Study of Tazemetostat in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Endometrial Cancer - Mayo Clinic

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

  2. Olaparib and Atezolizumab Either Alone or in Combination in Treating Patients With Stage III-IV Triple Negative Breast Cancer - Mayo Clinic

    Olaparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as atezolizumab, may interfere ...

  3. Patient Stories - Victor J. Davila, M.D. - Mayo Clinic

    Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.

  4. S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer - Mayo Clinic

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

  5. ECOSPOR III - SER-109 Versus Placebo in the Treatment of Adults With Recurrent Clostridium Difficile Infection - Mayo Clinic

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

  6. Ibrutinib and Ixazomib Citrate in Treating Participants With Relapsed or Refractory Waldenstrom Macroglobulinemia - Mayo Clinic

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

  7. H pylori - Present Management and Future Therapies

    We know that Helicobacter pylori infection can cause only peptic ulcer disease but dyspeptic symptoms in some patients and in a small percentage of patients can ...

  8. Patient Stories - Robert T. Fazzio, M.D., Ph.D. - Mayo Clinic

    Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.

  9. A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Depemokimab in Adults With Hypereosinophilic Syndrome (HES) - Mayo Clinic

    ... standard of care (SoC). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

  10. Mepivacaine Versus Bupivacaine Onset Time in Ultrasound-guided Ankle Blocks - Mayo Clinic

    Currently, standard of care is to perform ankles blocks with both mepivacaine and bupivacaine. However, given similarity in their safety profile, we would ...